NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells
Authors:
- 30 April 2014
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 393 (1-2) , 265-270
Abstract
Chemotherapy is a strategy for patients with advanced prostate cancer, especially those with castration-resistant prostate cancer. Prostate cancer stem cells (PCSCs) are believed to be the origin of cancer recurrence following therapy intervention, including chemotherapy. The mechanisms underlying the chemoresistance of PCSCs are still poorly understood. In the present study, fluorescence-activated cell sorting was used to isolate PCSCs from LNCaP and PC3 cell lines. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide was used to measure the cell viability. Quantitative real-time PCR and western blotting were utilized to evaluate the mRNA and protein levels. ShRNA was employed to knock down target gene expression. Chromatin immunoprecipitation (ChIP) was performed to explore the detailed mechanism underlying ABCC1 expression. Our results revealed that the sorted PCSCs showed enhanced chemoresistance ability than matched non-PCSCs. Protein level of activated form of NOTCH1(ICN1) was significantly higher in PCSCs. Inhibition of NOTCH1 with shRNA could decrease ABCC1 expression, and improve chemosensitivity in PCSCs. Finally, ChIP–PCR showed ICN1 could directly bind to the promoter region of ABCC1. In conclusion, NOTCH1 signaling could transactivate ABCC1, resulting in higher chemoresistance ability of PCSCs, which might be one of the important mechanisms underlying the chemoresistance of PCSCs.Keywords
This publication has 29 references indexed in Scilit:
- Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK mannerCarcinogenesis, 2013
- Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colonMolecular Cancer, 2013
- Notch1 Is Required for Kras-Induced Lung Adenocarcinoma and Controls Tumor Cell Survival via p53Cancer Research, 2013
- Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP CellsInternational Journal of Molecular Sciences, 2013
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating CellsCancer Cell, 2012
- Genome-Wide Analysis of N1ICD/RBPJ Targets In Vivo Reveals Direct Transcriptional Regulation of Wnt, SHH, and Hippo Pathway Effectors by Notch1Stem Cells, 2012
- Arsenic-Specific Stem Cell Selection During Malignant TransformationJNCI: Journal of the National Cancer Institute, 2010
- Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinomaInternational Journal of Cancer, 2009
- Prostate tumor-initiating cells: A new target for telomerase inhibition therapy?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- CD133, a novel marker for human prostatic epithelial stem cellsJournal of Cell Science, 2004